Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Diagnosed”

222 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 222 results

Not applicableLooking for participantsNCT06202118
What this trial is testing

Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Who this might be right for
Breast CancerRecurrent Breast CancerBreast Carcinoma
Alpha Tau Medical LTD. 10
Not applicableLooking for participantsNCT06446882
What this trial is testing

Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerEarly-stage Breast Cancer
Fundacio Clinic Barcelona 304
Not applicableStudy completedNCT01220960
What this trial is testing

Art Therapy Intervention for Breast Cancer Patients

Who this might be right for
Breast Cancer
Dr. Sarkis Meterissian 64
Not applicableNot Yet RecruitingNCT07012707
What this trial is testing

Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 172
Large-scale testing (Phase 3)Study completedNCT06597175
What this trial is testing

Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy

Who this might be right for
Breast CancerBreast TumorMammary Carcinoma, Human
Olive Healthcare 300
Not applicableStudy completedNCT00390962
What this trial is testing

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

Who this might be right for
StrokeTransient Ischemic Attack
University Hospital, Basel, Switzerland 469
Not applicableNot Yet RecruitingNCT06497322
What this trial is testing

Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment

Who this might be right for
Breast CancerTriple Negative Breast Cancer
University Hospital of Cologne 60
Testing effectiveness (Phase 2)Study completedNCT01832051
What this trial is testing

Clinical Value of 89Zr-trastuzumab PET

Who this might be right for
Metastatic Breast Cancer
University Medical Center Groningen 20
Not applicableUnknownNCT00938756
What this trial is testing

Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerMetastatic Cancer
Centre Oscar Lambret 80
Testing effectiveness (Phase 2)Study completedNCT02282345
What this trial is testing

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

Who this might be right for
Breast AdenocarcinomaDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+2 more
M.D. Anderson Cancer Center 36
Not applicableLooking for participantsNCT06474988
What this trial is testing

Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients

Who this might be right for
Breast CancerEstrogen Receptor Positive Tumor
European Institute of Oncology 150
Testing effectiveness (Phase 2)WithdrawnNCT03065712
What this trial is testing

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center
Not applicableUnknownNCT02479100
What this trial is testing

Contrast Enhanced Spectral Mammography (CESM) Study

Who this might be right for
Breast Cancer
Cambridge University Hospitals NHS Foundation Trust 103
Testing effectiveness (Phase 2)Looking for participantsNCT05664893
What this trial is testing

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)

Who this might be right for
HER2 Negative Breast Cancer Not Immediately Operated
Centre Antoine Lacassagne 85
Large-scale testing (Phase 3)WithdrawnNCT02929576
What this trial is testing

Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer
Pfizer
Not applicableStudy completedNCT04498611
What this trial is testing

Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy

Who this might be right for
Carcinoma, Ductal, BreastInvasive Breast CancerIMAGE
Seoul National University Hospital 113
Not applicableStudy completedNCT00089323
What this trial is testing

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,630
Not applicableEnded earlyNCT00740961
What this trial is testing

Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+1 more
Case Comprehensive Cancer Center 63
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT01201265
What this trial is testing

Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 40
Load More Results